

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.72186476 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 8.87765583 |
| 3 | angiotensin maturation (GO:0002003) | 8.06413894 |
| 4 | actin filament depolymerization (GO:0030042) | 6.16948859 |
| 5 | flavonoid metabolic process (GO:0009812) | 5.81419929 |
| 6 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.70503907 |
| 7 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.70503907 |
| 8 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.68814429 |
| 9 | drug catabolic process (GO:0042737) | 5.41766792 |
| 10 | bile acid and bile salt transport (GO:0015721) | 5.38105592 |
| 11 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.37101520 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.35870847 |
| 13 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.31212631 |
| 14 | sulfate transmembrane transport (GO:1902358) | 5.31080706 |
| 15 | vitamin A metabolic process (GO:0006776) | 5.18764011 |
| 16 | regulation of bile acid biosynthetic process (GO:0070857) | 5.07371601 |
| 17 | intestinal epithelial cell development (GO:0060576) | 5.05927069 |
| 18 | digestive system process (GO:0022600) | 4.88821538 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.77195257 |
| 20 | response to hepatocyte growth factor (GO:0035728) | 4.73381721 |
| 21 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.73381721 |
| 22 | sulfur compound transport (GO:0072348) | 4.53369331 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.38029123 |
| 24 | sulfate transport (GO:0008272) | 4.34141517 |
| 25 | modified amino acid transport (GO:0072337) | 4.33098010 |
| 26 | glucose 6-phosphate metabolic process (GO:0051156) | 4.32214765 |
| 27 | adhesion of symbiont to host cell (GO:0044650) | 4.31191159 |
| 28 | virion attachment to host cell (GO:0019062) | 4.31191159 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31186721 |
| 30 | epithelial structure maintenance (GO:0010669) | 4.23017420 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.22506548 |
| 32 | mannose metabolic process (GO:0006013) | 4.20039573 |
| 33 | digestion (GO:0007586) | 4.13181205 |
| 34 | drug transmembrane transport (GO:0006855) | 4.09358746 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 4.05666024 |
| 36 | O-glycan processing (GO:0016266) | 4.03035231 |
| 37 | bicarbonate transport (GO:0015701) | 4.00645478 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99138910 |
| 39 | drug transport (GO:0015893) | 3.96144302 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.91822702 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.91822702 |
| 42 | sulfation (GO:0051923) | 3.90968567 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83771386 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82539108 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.79958333 |
| 46 | detection of bacterium (GO:0016045) | 3.79339997 |
| 47 | detection of other organism (GO:0098543) | 3.75012621 |
| 48 | exogenous drug catabolic process (GO:0042738) | 3.73459497 |
| 49 | hormone catabolic process (GO:0042447) | 3.70965464 |
| 50 | lipoprotein metabolic process (GO:0042157) | 3.70086185 |
| 51 | transcytosis (GO:0045056) | 3.69107033 |
| 52 | phospholipid efflux (GO:0033700) | 3.59577560 |
| 53 | regulation of guanylate cyclase activity (GO:0031282) | 3.59267346 |
| 54 | desmosome organization (GO:0002934) | 3.57011443 |
| 55 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.48908083 |
| 56 | hemidesmosome assembly (GO:0031581) | 3.48201890 |
| 57 | peptide hormone processing (GO:0016486) | 3.46467264 |
| 58 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.45727174 |
| 59 | striated muscle atrophy (GO:0014891) | 3.44686639 |
| 60 | cGMP-mediated signaling (GO:0019934) | 3.43968731 |
| 61 | adhesion of symbiont to host (GO:0044406) | 3.36832041 |
| 62 | oligosaccharide catabolic process (GO:0009313) | 3.36231949 |
| 63 | lipoprotein transport (GO:0042953) | 3.34844606 |
| 64 | peptide catabolic process (GO:0043171) | 3.32954810 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 3.29835262 |
| 66 | renal absorption (GO:0070293) | 3.28636380 |
| 67 | sperm capacitation (GO:0048240) | 3.28067558 |
| 68 | response to peptidoglycan (GO:0032494) | 3.25624030 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.25621565 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 3.25469209 |
| 71 | regulation of actin nucleation (GO:0051125) | 3.25067336 |
| 72 | thrombin receptor signaling pathway (GO:0070493) | 3.24840729 |
| 73 | positive thymic T cell selection (GO:0045059) | 3.23877180 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23216123 |
| 75 | germinal center formation (GO:0002467) | 3.21378842 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.20759176 |
| 77 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.20666818 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.20647317 |
| 79 | cholesterol homeostasis (GO:0042632) | 3.19530488 |
| 80 | sterol homeostasis (GO:0055092) | 3.19444482 |
| 81 | regulation of viral release from host cell (GO:1902186) | 3.19294053 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.18936665 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.18936665 |
| 84 | thyroid hormone metabolic process (GO:0042403) | 3.16619081 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 3.16354261 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15304946 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15304946 |
| 88 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.14886391 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 3.14495332 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14495332 |
| 91 | modulation by symbiont of host defense response (GO:0052031) | 3.14495332 |
| 92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14495332 |
| 93 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14495332 |
| 94 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14495332 |
| 95 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.13362894 |
| 96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13324144 |
| 97 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.12313807 |
| 98 | negative regulation of granulocyte differentiation (GO:0030853) | 3.12262641 |
| 99 | protein-lipid complex assembly (GO:0065005) | 3.11884759 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09441920 |
| 101 | hepatocyte apoptotic process (GO:0097284) | 3.07763212 |
| 102 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.06889511 |
| 103 | vitamin transmembrane transport (GO:0035461) | 3.05553187 |
| 104 | regulation of cellular extravasation (GO:0002691) | 3.05061844 |
| 105 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.01968392 |
| 106 | epithelial cell-cell adhesion (GO:0090136) | 3.00323578 |
| 107 | cytidine catabolic process (GO:0006216) | 2.99981070 |
| 108 | cytidine deamination (GO:0009972) | 2.99981070 |
| 109 | cytidine metabolic process (GO:0046087) | 2.99981070 |
| 110 | transepithelial transport (GO:0070633) | 2.97706061 |
| 111 | regulation of mast cell degranulation (GO:0043304) | 2.97539776 |
| 112 | regulation of triglyceride catabolic process (GO:0010896) | 2.97499574 |
| 113 | skeletal muscle adaptation (GO:0043501) | 2.97120007 |
| 114 | antibacterial humoral response (GO:0019731) | 2.96119051 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95808232 |
| 116 | regulation of cholesterol esterification (GO:0010872) | 2.95639228 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 2.95070399 |
| 118 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.93892158 |
| 119 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.93892158 |
| 120 | endocrine process (GO:0050886) | 2.93892158 |
| 121 | antimicrobial humoral response (GO:0019730) | 2.93447941 |
| 122 | detection of external biotic stimulus (GO:0098581) | 2.93036653 |
| 123 | phospholipid scrambling (GO:0017121) | 2.92546029 |
| 124 | diacylglycerol metabolic process (GO:0046339) | 2.91732591 |
| 125 | cellular glucuronidation (GO:0052695) | 2.90298747 |
| 126 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.88114265 |
| 127 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.88114265 |
| 128 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.88114265 |
| 129 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.88104675 |
| 130 | drug metabolic process (GO:0017144) | 2.85549554 |
| 131 | muscle atrophy (GO:0014889) | 2.82774260 |
| 132 | cellular extravasation (GO:0045123) | 2.81960188 |
| 133 | vitamin transport (GO:0051180) | 2.80431949 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78944530 |
| 135 | nucleotide-sugar metabolic process (GO:0009225) | 2.78425760 |
| 136 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.77409134 |
| 137 | regulation of vitamin metabolic process (GO:0030656) | 2.76994963 |
| 138 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.75255445 |
| 139 | thymic T cell selection (GO:0045061) | 2.75195205 |
| 140 | negative regulation of interleukin-8 production (GO:0032717) | 2.73552664 |
| 141 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72991753 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 2.71890519 |
| 143 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71280446 |
| 144 | T cell selection (GO:0045058) | 2.70177199 |
| 145 | regulation of ARF GTPase activity (GO:0032312) | 2.68337032 |
| 146 | negative thymic T cell selection (GO:0045060) | 2.66673343 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64466446 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 2.62629174 |
| 149 | detection of biotic stimulus (GO:0009595) | 2.59790762 |
| 150 | regulation of antigen processing and presentation (GO:0002577) | 2.56641929 |
| 151 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.53313625 |
| 152 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.49827631 |
| 153 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.46133713 |
| 154 | negative regulation of myotube differentiation (GO:0010832) | 2.45269874 |
| 155 | positive T cell selection (GO:0043368) | 2.45056811 |
| 156 | leukocyte aggregation (GO:0070486) | 2.44861868 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44604756 |
| 158 | negative T cell selection (GO:0043383) | 2.44442988 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44349308 |
| 160 | regulation of tolerance induction (GO:0002643) | 2.42270278 |
| 161 | positive regulation of histone deacetylation (GO:0031065) | 2.40669999 |
| 162 | neutrophil activation (GO:0042119) | 2.40653812 |
| 163 | regulation of regulated secretory pathway (GO:1903305) | 2.40006898 |
| 164 | macrophage activation (GO:0042116) | 2.38898163 |
| 165 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.38541984 |
| 166 | leukotriene metabolic process (GO:0006691) | 2.38526129 |
| 167 | regulation of granulocyte differentiation (GO:0030852) | 2.36908636 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36787954 |
| 169 | cellular response to exogenous dsRNA (GO:0071360) | 2.34361173 |
| 170 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34219420 |
| 171 | defense response to protozoan (GO:0042832) | 2.33733385 |
| 172 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31770330 |
| 173 | response to type I interferon (GO:0034340) | 2.30938517 |
| 174 | regulation of necroptotic process (GO:0060544) | 2.30813092 |
| 175 | glycosphingolipid catabolic process (GO:0046479) | 2.30542177 |
| 176 | regulation of B cell differentiation (GO:0045577) | 2.29997319 |
| 177 | regulation of T cell tolerance induction (GO:0002664) | 2.28793119 |
| 178 | negative regulation of interleukin-12 production (GO:0032695) | 2.28110749 |
| 179 | negative regulation of innate immune response (GO:0045824) | 2.27791636 |
| 180 | NIK/NF-kappaB signaling (GO:0038061) | 2.27758297 |
| 181 | histone H3-K36 demethylation (GO:0070544) | 2.26219187 |
| 182 | dendritic cell chemotaxis (GO:0002407) | 2.25847561 |
| 183 | positive regulation of protein deacetylation (GO:0090312) | 2.25607544 |
| 184 | regulation of respiratory burst (GO:0060263) | 2.22881607 |
| 185 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.22697247 |
| 186 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.22534709 |
| 187 | type I interferon signaling pathway (GO:0060337) | 2.22420163 |
| 188 | cellular response to type I interferon (GO:0071357) | 2.22420163 |
| 189 | mature B cell differentiation involved in immune response (GO:0002313) | 2.22236639 |
| 190 | cellular response to reactive nitrogen species (GO:1902170) | 2.22048875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.35678788 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.33231231 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.84825646 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.73109572 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03290574 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96937184 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.90759083 |
| 8 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.89531981 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87781598 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.82374226 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.82358941 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.76839495 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.75205153 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.68678083 |
| 15 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.65208971 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.58799543 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45870477 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44575696 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32792019 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32128783 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31745446 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.19700977 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18502263 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12546290 |
| 25 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.09657793 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07609435 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05070594 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.04129100 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01313917 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00720830 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98950606 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97827826 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96800747 |
| 34 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95665078 |
| 35 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.95316193 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91950333 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87870113 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85771065 |
| 39 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.83614221 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78404289 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.77397779 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76645581 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73920910 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73711329 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73065592 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72656433 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.71175274 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.70302093 |
| 49 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69898897 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69176979 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68965229 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68615705 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68491848 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67107034 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66432800 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.64959062 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62244046 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60253181 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57761162 |
| 60 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56834939 |
| 61 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55751626 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54661671 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52140059 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49974775 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48809721 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46007784 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45401545 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44123335 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.43777433 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43685247 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43292470 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42402887 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.41981992 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.41733547 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40463430 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.39783256 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39574767 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39505135 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38292259 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38135022 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36944697 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36848830 |
| 83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35205142 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.31766650 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31376261 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30173326 |
| 87 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28209630 |
| 88 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28135819 |
| 89 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25752412 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25133122 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24259269 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24070610 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23800978 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23297168 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23227562 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.22856852 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22574441 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22377347 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22097637 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21659011 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20380631 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20308406 |
| 103 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19774028 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19760134 |
| 105 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.18799895 |
| 106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18592749 |
| 107 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18490768 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17893286 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17765660 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.17419776 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16513777 |
| 112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16150589 |
| 113 | MYB_26560356_Chip-Seq_TH2_Human | 1.15970636 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15195490 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15011799 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14769528 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13701296 |
| 118 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12784878 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12608840 |
| 120 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12325316 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11902799 |
| 122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11778329 |
| 123 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09939851 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08423809 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07644875 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06929881 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06612675 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06260299 |
| 129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05596523 |
| 130 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05543962 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05310630 |
| 132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05000458 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04732619 |
| 134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04667786 |
| 135 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04536385 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04093726 |
| 137 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02282377 |
| 138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98837741 |
| 139 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97769288 |
| 140 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97489077 |
| 141 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97489077 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97450903 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97416608 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96066333 |
| 145 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94661639 |
| 146 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93274370 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92409388 |
| 148 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91792849 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91474004 |
| 150 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90929118 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90855605 |
| 152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89416429 |
| 153 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88628532 |
| 154 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88600642 |
| 155 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88314307 |
| 156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87053374 |
| 157 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85757266 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85696141 |
| 159 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85344366 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84441440 |
| 161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82582971 |
| 162 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82264315 |
| 163 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82073803 |
| 164 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81731473 |
| 165 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80012698 |
| 166 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78934604 |
| 167 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78778833 |
| 168 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78729942 |
| 169 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.77327571 |
| 170 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.75378654 |
| 171 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.74235670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.24642653 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.75827084 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.13758853 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.05063384 |
| 5 | MP0003866_abnormal_defecation | 3.44327020 |
| 6 | MP0003878_abnormal_ear_physiology | 3.42546227 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.42546227 |
| 8 | MP0003436_decreased_susceptibility_to | 3.36667798 |
| 9 | MP0002822_catalepsy | 3.31358819 |
| 10 | MP0000462_abnormal_digestive_system | 3.29617876 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.14281180 |
| 12 | MP0003303_peritoneal_inflammation | 2.95047134 |
| 13 | MP0003724_increased_susceptibility_to | 2.90921225 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.84336180 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83167702 |
| 16 | MP0003252_abnormal_bile_duct | 2.64502739 |
| 17 | MP0003283_abnormal_digestive_organ | 2.62197898 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.61755046 |
| 19 | MP0004043_abnormal_pH_regulation | 2.59044579 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.57915619 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.41282405 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.29280650 |
| 23 | MP0005381_digestive/alimentary_phenotyp | 2.25776146 |
| 24 | MP0001663_abnormal_digestive_system | 2.24345471 |
| 25 | MP0009840_abnormal_foam_cell | 2.21033120 |
| 26 | MP0005025_abnormal_response_to | 2.20791090 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.18543299 |
| 28 | MP0002419_abnormal_innate_immunity | 2.17627200 |
| 29 | MP0001873_stomach_inflammation | 2.12502896 |
| 30 | MP0005365_abnormal_bile_salt | 2.11229539 |
| 31 | MP0005409_darkened_coat_color | 2.08337213 |
| 32 | MP0001790_abnormal_immune_system | 2.07275094 |
| 33 | MP0005387_immune_system_phenotype | 2.07275094 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.05470580 |
| 35 | MP0001800_abnormal_humoral_immune | 2.05309260 |
| 36 | MP0000538_abnormal_urinary_bladder | 2.00097869 |
| 37 | MP0009278_abnormal_bone_marrow | 1.96031416 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.92318523 |
| 39 | MP0001664_abnormal_digestion | 1.91848586 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.90691147 |
| 41 | MP0000477_abnormal_intestine_morphology | 1.86568128 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.84514847 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.82330351 |
| 44 | MP0000490_abnormal_crypts_of | 1.79414259 |
| 45 | MP0000685_abnormal_immune_system | 1.76587402 |
| 46 | MP0009785_altered_susceptibility_to | 1.73505505 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.73367618 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.73013302 |
| 49 | MP0002723_abnormal_immune_serum | 1.72809932 |
| 50 | MP0008260_abnormal_autophagy | 1.72251121 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.71093253 |
| 52 | MP0001819_abnormal_immune_cell | 1.70177440 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.69744369 |
| 54 | MP0006082_CNS_inflammation | 1.69725230 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.69220259 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.68037088 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.64490111 |
| 58 | MP0005671_abnormal_response_to | 1.63804941 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.63767731 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.63601096 |
| 61 | MP0002796_impaired_skin_barrier | 1.63456831 |
| 62 | MP0001765_abnormal_ion_homeostasis | 1.63216880 |
| 63 | MP0003315_abnormal_perineum_morphology | 1.60266962 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.60250932 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.58749586 |
| 66 | MP0004147_increased_porphyrin_level | 1.53554576 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.52402118 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.50367411 |
| 69 | MP0005670_abnormal_white_adipose | 1.48266483 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.44410460 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.41608134 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.38952641 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.38270245 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.38270245 |
| 75 | MP0002933_joint_inflammation | 1.36220421 |
| 76 | MP0000716_abnormal_immune_system | 1.31805260 |
| 77 | MP0003828_pulmonary_edema | 1.31603688 |
| 78 | MP0002405_respiratory_system_inflammati | 1.27133614 |
| 79 | MP0001849_ear_inflammation | 1.27112414 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.24492900 |
| 81 | MP0002132_abnormal_respiratory_system | 1.24297711 |
| 82 | MP0002398_abnormal_bone_marrow | 1.22910947 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.22141860 |
| 84 | MP0010678_abnormal_skin_adnexa | 1.18521076 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 1.18274754 |
| 86 | MP0003868_abnormal_feces_composition | 1.18045959 |
| 87 | MP0005332_abnormal_amino_acid | 1.17251632 |
| 88 | MP0008469_abnormal_protein_level | 1.16271675 |
| 89 | MP0008004_abnormal_stomach_pH | 1.13785918 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 1.12992857 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.12433925 |
| 92 | MP0006054_spinal_hemorrhage | 1.09395360 |
| 93 | MP0002009_preneoplasia | 1.08575193 |
| 94 | MP0004510_myositis | 1.03766619 |
| 95 | MP0003879_abnormal_hair_cell | 1.03143566 |
| 96 | MP0002429_abnormal_blood_cell | 1.02858351 |
| 97 | MP0000249_abnormal_blood_vessel | 1.02304290 |
| 98 | MP0005501_abnormal_skin_physiology | 1.01844293 |
| 99 | MP0009115_abnormal_fat_cell | 1.00434133 |
| 100 | MP0003279_aneurysm | 0.99055394 |
| 101 | MP0004947_skin_inflammation | 0.99045926 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.97130515 |
| 103 | MP0001851_eye_inflammation | 0.96452778 |
| 104 | MP0005535_abnormal_body_temperature | 0.95915836 |
| 105 | MP0002722_abnormal_immune_system | 0.94917819 |
| 106 | MP0003690_abnormal_glial_cell | 0.93844165 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.92363743 |
| 108 | MP0005310_abnormal_salivary_gland | 0.92204730 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.92095594 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.91994124 |
| 111 | MP0005448_abnormal_energy_balance | 0.91871024 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.91480643 |
| 113 | MP0002971_abnormal_brown_adipose | 0.91050318 |
| 114 | MP0000858_altered_metastatic_potential | 0.90798360 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.90566482 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.89204913 |
| 117 | MP0001958_emphysema | 0.88202770 |
| 118 | MP0003091_abnormal_cell_migration | 0.87803851 |
| 119 | MP0001756_abnormal_urination | 0.86275688 |
| 120 | MP0003075_altered_response_to | 0.86113465 |
| 121 | MP0002089_abnormal_postnatal_growth/wei | 0.84597670 |
| 122 | MP0004381_abnormal_hair_follicle | 0.83938005 |
| 123 | MP0009764_decreased_sensitivity_to | 0.83304769 |
| 124 | MP0000609_abnormal_liver_physiology | 0.82743421 |
| 125 | MP0005166_decreased_susceptibility_to | 0.82641140 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.81119516 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.80697887 |
| 128 | MP0005390_skeleton_phenotype | 0.79872429 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.77841174 |
| 130 | MP0000470_abnormal_stomach_morphology | 0.77375821 |
| 131 | MP0002254_reproductive_system_inflammat | 0.75066050 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.73342312 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.71932089 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.71377399 |
| 135 | MP0009053_abnormal_anal_canal | 0.70919445 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.68612968 |
| 137 | MP0008872_abnormal_physiological_respon | 0.67375888 |
| 138 | MP0002138_abnormal_hepatobiliary_system | 0.65609314 |
| 139 | MP0003941_abnormal_skin_development | 0.61769654 |
| 140 | MP0000516_abnormal_urinary_system | 0.57040443 |
| 141 | MP0005367_renal/urinary_system_phenotyp | 0.57040443 |
| 142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54787411 |
| 143 | MP0005451_abnormal_body_composition | 0.53478007 |
| 144 | MP0001764_abnormal_homeostasis | 0.52562225 |
| 145 | MP0008961_abnormal_basal_metabolism | 0.51581126 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.50359065 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.47358022 |
| 148 | MP0000613_abnormal_salivary_gland | 0.47226687 |
| 149 | MP0004858_abnormal_nervous_system | 0.46720992 |
| 150 | MP0005266_abnormal_metabolism | 0.45988544 |
| 151 | MP0004185_abnormal_adipocyte_glucose | 0.45752256 |
| 152 | MP0002060_abnormal_skin_morphology | 0.45407106 |
| 153 | MP0000377_abnormal_hair_follicle | 0.44140582 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.42480958 |
| 155 | MP0000230_abnormal_systemic_arterial | 0.40868761 |
| 156 | MP0005023_abnormal_wound_healing | 0.40742462 |
| 157 | MP0008873_increased_physiological_sensi | 0.40676815 |
| 158 | MP0002277_abnormal_respiratory_mucosa | 0.40267879 |
| 159 | MP0004270_analgesia | 0.40094277 |
| 160 | MP0002234_abnormal_pharynx_morphology | 0.39973715 |
| 161 | MP0002896_abnormal_bone_mineralization | 0.39760425 |
| 162 | MP0005666_abnormal_adipose_tissue | 0.39698183 |
| 163 | MP0003045_fibrosis | 0.39612764 |
| 164 | MP0001845_abnormal_inflammatory_respons | 0.37046665 |
| 165 | MP0001485_abnormal_pinna_reflex | 0.36900774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.10541733 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.45021162 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 5.32257770 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 5.27801475 |
| 5 | Malnutrition (HP:0004395) | 5.01478346 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.72764443 |
| 7 | Metabolic alkalosis (HP:0200114) | 4.60239529 |
| 8 | Cupped ribs (HP:0000887) | 4.48445431 |
| 9 | Flat acetabular roof (HP:0003180) | 4.47760758 |
| 10 | Acanthocytosis (HP:0001927) | 4.40893549 |
| 11 | Abdominal distention (HP:0003270) | 4.32321699 |
| 12 | Abnormality of chloride homeostasis (HP:0011422) | 4.15991070 |
| 13 | Hydroxyprolinuria (HP:0003080) | 4.14153677 |
| 14 | Abnormality of proline metabolism (HP:0010907) | 4.14153677 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.98863750 |
| 16 | Abnormal tarsal ossification (HP:0008369) | 3.86006538 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.81614671 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.81414067 |
| 19 | Widely patent fontanelles and sutures (HP:0004492) | 3.47774899 |
| 20 | Chronic diarrhea (HP:0002028) | 3.44628516 |
| 21 | Abnormality of the 1st metacarpal (HP:0010009) | 3.44277599 |
| 22 | Colitis (HP:0002583) | 3.42738062 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.35305949 |
| 24 | Dehydration (HP:0001944) | 3.33407734 |
| 25 | Fat malabsorption (HP:0002630) | 3.31243554 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.28489300 |
| 27 | Myositis (HP:0100614) | 3.28487789 |
| 28 | Gingivitis (HP:0000230) | 3.27136656 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 3.24855597 |
| 30 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.24340470 |
| 31 | Villous atrophy (HP:0011473) | 3.24340470 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.19484829 |
| 33 | Obstructive sleep apnea (HP:0002870) | 3.17392347 |
| 34 | Gastrointestinal dysmotility (HP:0002579) | 3.09410552 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.06399291 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03466798 |
| 37 | Abnormality of carpal bone ossification (HP:0006257) | 3.01660921 |
| 38 | Recurrent fungal infections (HP:0002841) | 3.01423651 |
| 39 | Increased IgE level (HP:0003212) | 2.97819072 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94245468 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.94030859 |
| 42 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.93398709 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.93002496 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.91100125 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89848947 |
| 46 | Pustule (HP:0200039) | 2.88173243 |
| 47 | Abnormality of the fingertips (HP:0001211) | 2.82223919 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.78933335 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.77708729 |
| 50 | Abnormal foot bone ossification (HP:0010675) | 2.76478758 |
| 51 | Congenital sensorineural hearing impairment (HP:0008527) | 2.75783130 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.75371832 |
| 53 | Abnormality of vitamin B metabolism (HP:0004340) | 2.75163941 |
| 54 | Milia (HP:0001056) | 2.74754842 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.74698550 |
| 56 | Hyperglycinuria (HP:0003108) | 2.74141780 |
| 57 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.73822794 |
| 58 | Orchitis (HP:0100796) | 2.69726505 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.68864707 |
| 60 | Broad face (HP:0000283) | 2.68785113 |
| 61 | Hyperaldosteronism (HP:0000859) | 2.67918735 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.67668576 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.66599697 |
| 64 | Progressive sensorineural hearing impairment (HP:0000408) | 2.66241435 |
| 65 | Meningitis (HP:0001287) | 2.64793597 |
| 66 | Cellulitis (HP:0100658) | 2.62628872 |
| 67 | Potter facies (HP:0002009) | 2.62164654 |
| 68 | Facial shape deformation (HP:0011334) | 2.62164654 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.61712317 |
| 70 | Ureteral stenosis (HP:0000071) | 2.60347637 |
| 71 | Fragile nails (HP:0001808) | 2.59637998 |
| 72 | Glomerulonephritis (HP:0000099) | 2.58798949 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.58644677 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.58644677 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.56469075 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.54690906 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.53966366 |
| 78 | Glycosuria (HP:0003076) | 2.53966366 |
| 79 | Alkalosis (HP:0001948) | 2.50899742 |
| 80 | Woolly hair (HP:0002224) | 2.49940111 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.47613988 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.45770127 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45770127 |
| 84 | Abnormal biliary tract morphology (HP:0012440) | 2.45122868 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44228594 |
| 86 | Thin bony cortex (HP:0002753) | 2.42601500 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42090890 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42090890 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42090890 |
| 90 | Vasculitis (HP:0002633) | 2.41864133 |
| 91 | Nephrolithiasis (HP:0000787) | 2.41812583 |
| 92 | Hemoptysis (HP:0002105) | 2.41425659 |
| 93 | Ureteral obstruction (HP:0006000) | 2.41217270 |
| 94 | Recurrent skin infections (HP:0001581) | 2.40990256 |
| 95 | Poikilocytosis (HP:0004447) | 2.39932173 |
| 96 | Amyloidosis (HP:0011034) | 2.39867263 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 2.39565623 |
| 98 | Hypolipoproteinemia (HP:0010981) | 2.36886439 |
| 99 | Pili torti (HP:0003777) | 2.36100222 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35520538 |
| 101 | Obstructive lung disease (HP:0006536) | 2.35520538 |
| 102 | Recurrent viral infections (HP:0004429) | 2.35398814 |
| 103 | Short phalanx of the thumb (HP:0009660) | 2.35048277 |
| 104 | Mediastinal lymphadenopathy (HP:0100721) | 2.34640716 |
| 105 | Abnormality of complement system (HP:0005339) | 2.34578609 |
| 106 | Symptomatic seizures (HP:0011145) | 2.33319709 |
| 107 | Abnormal hand bone ossification (HP:0010660) | 2.32427784 |
| 108 | Complement deficiency (HP:0004431) | 2.31549160 |
| 109 | Chest pain (HP:0100749) | 2.31370227 |
| 110 | Palpitations (HP:0001962) | 2.31279651 |
| 111 | Epistaxis (HP:0000421) | 2.30820649 |
| 112 | Alopecia of scalp (HP:0002293) | 2.29930058 |
| 113 | Progressive hearing impairment (HP:0001730) | 2.29886028 |
| 114 | Decreased circulating renin level (HP:0003351) | 2.27816134 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 2.24508476 |
| 116 | Optic neuritis (HP:0100653) | 2.24508476 |
| 117 | Encephalitis (HP:0002383) | 2.23485588 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 2.23342927 |
| 119 | Hyperparathyroidism (HP:0000843) | 2.23018616 |
| 120 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.22557949 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 2.19414761 |
| 122 | Late onset (HP:0003584) | 2.18957768 |
| 123 | Flattened epiphyses (HP:0003071) | 2.18011336 |
| 124 | Hypokalemia (HP:0002900) | 2.17782200 |
| 125 | Pigmentary retinal degeneration (HP:0001146) | 2.17471103 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 2.16951251 |
| 127 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16600982 |
| 128 | Hyperphosphaturia (HP:0003109) | 2.15873398 |
| 129 | Emphysema (HP:0002097) | 2.14982952 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 2.14933912 |
| 131 | Atrophic scars (HP:0001075) | 2.14472880 |
| 132 | Pulmonary infiltrates (HP:0002113) | 2.14077495 |
| 133 | Xanthomatosis (HP:0000991) | 2.13608934 |
| 134 | Increased cerebral lipofuscin (HP:0011813) | 2.13164410 |
| 135 | Biliary tract neoplasm (HP:0100574) | 2.12859679 |
| 136 | Syncope (HP:0001279) | 2.12246172 |
| 137 | Wide cranial sutures (HP:0010537) | 2.09828309 |
| 138 | Polycythemia (HP:0001901) | 2.09676721 |
| 139 | Abnormality of the gastric mucosa (HP:0004295) | 2.09155592 |
| 140 | Cervical subluxation (HP:0003308) | 2.07367813 |
| 141 | Osteomyelitis (HP:0002754) | 2.06854680 |
| 142 | Proximal tubulopathy (HP:0000114) | 2.06715656 |
| 143 | Hypertriglyceridemia (HP:0002155) | 2.04268026 |
| 144 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03529359 |
| 145 | Cone-rod dystrophy (HP:0000548) | 2.03364792 |
| 146 | Sensorimotor neuropathy (HP:0007141) | 2.02369534 |
| 147 | Neonatal short-limb short stature (HP:0008921) | 2.01980411 |
| 148 | Nephritis (HP:0000123) | 2.01926390 |
| 149 | Hoarse voice (HP:0001609) | 2.01751583 |
| 150 | Micronodular cirrhosis (HP:0001413) | 2.01748882 |
| 151 | Polygenic inheritance (HP:0010982) | 2.00818043 |
| 152 | Aneurysm (HP:0002617) | 1.95421527 |
| 153 | Papilledema (HP:0001085) | 1.95139803 |
| 154 | Abnormal urine phosphate concentration (HP:0012599) | 1.95030037 |
| 155 | Lymphangioma (HP:0100764) | 1.94755270 |
| 156 | Granulocytopenia (HP:0001913) | 1.93815535 |
| 157 | Delayed epiphyseal ossification (HP:0002663) | 1.93132177 |
| 158 | Breech presentation (HP:0001623) | 1.93028471 |
| 159 | Plantar hyperkeratosis (HP:0007556) | 1.92605152 |
| 160 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92450706 |
| 161 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92335090 |
| 162 | Restrictive lung disease (HP:0002091) | 1.92316098 |
| 163 | Confusion (HP:0001289) | 1.91478029 |
| 164 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91163384 |
| 165 | Vacuolated lymphocytes (HP:0001922) | 1.91012147 |
| 166 | Petechiae (HP:0000967) | 1.88781590 |
| 167 | Gastrointestinal stroma tumor (HP:0100723) | 1.88534529 |
| 168 | Onycholysis (HP:0001806) | 1.88259175 |
| 169 | Keratoconjunctivitis sicca (HP:0001097) | 1.86554765 |
| 170 | Myopathic facies (HP:0002058) | 1.86317421 |
| 171 | Hypophosphatemia (HP:0002148) | 1.85887296 |
| 172 | Protuberant abdomen (HP:0001538) | 1.85875280 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.85683960 |
| 174 | Cheilitis (HP:0100825) | 1.84768833 |
| 175 | Joint stiffness (HP:0001387) | 1.84447033 |
| 176 | Abnormality of the nasal mucosa (HP:0000433) | 1.83937250 |
| 177 | Metaphyseal cupping (HP:0003021) | 1.83712870 |
| 178 | Stomatitis (HP:0010280) | 1.82139911 |
| 179 | Hypochromic anemia (HP:0001931) | 1.81302382 |
| 180 | Distal lower limb amyotrophy (HP:0008944) | 1.80675530 |
| 181 | Loss of speech (HP:0002371) | 1.80378801 |
| 182 | Thoracic kyphosis (HP:0002942) | 1.80028047 |
| 183 | Visceral angiomatosis (HP:0100761) | 1.77833004 |
| 184 | Gingival bleeding (HP:0000225) | 1.76923286 |
| 185 | Asymmetric septal hypertrophy (HP:0001670) | 1.76232009 |
| 186 | Deformed sella turcica (HP:0002681) | 1.74230926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.20372755 |
| 2 | MST1R | 5.19204322 |
| 3 | FRK | 4.77141267 |
| 4 | LMTK2 | 3.80684692 |
| 5 | PIK3CA | 3.59499974 |
| 6 | MAP2K2 | 3.24990455 |
| 7 | TRIB3 | 3.12695077 |
| 8 | MAP4K1 | 3.02089749 |
| 9 | PRKG2 | 2.96555768 |
| 10 | NME1 | 2.90233568 |
| 11 | GRK6 | 2.84066351 |
| 12 | PRPF4B | 2.81840083 |
| 13 | EPHB2 | 2.61003847 |
| 14 | RIPK1 | 2.53138317 |
| 15 | TNK2 | 2.50279683 |
| 16 | EPHA2 | 2.50044010 |
| 17 | MAP3K2 | 2.33338107 |
| 18 | TAOK3 | 2.33323334 |
| 19 | TYK2 | 2.28411718 |
| 20 | BLK | 2.14313811 |
| 21 | SIK1 | 1.90108633 |
| 22 | PTK6 | 1.90052445 |
| 23 | ZAP70 | 1.86846964 |
| 24 | TESK1 | 1.85219344 |
| 25 | MET | 1.84420959 |
| 26 | MAP2K3 | 1.80469647 |
| 27 | FES | 1.76353878 |
| 28 | TAOK1 | 1.73463009 |
| 29 | TBK1 | 1.71070620 |
| 30 | MYLK | 1.68809642 |
| 31 | AKT3 | 1.67591612 |
| 32 | MAP3K10 | 1.62067030 |
| 33 | MARK2 | 1.52643424 |
| 34 | ERN1 | 1.52162552 |
| 35 | WNK4 | 1.51483880 |
| 36 | KIT | 1.51468349 |
| 37 | BTK | 1.49599288 |
| 38 | MAP3K13 | 1.48206786 |
| 39 | DDR2 | 1.43257569 |
| 40 | MAP3K6 | 1.38212850 |
| 41 | KSR2 | 1.35530274 |
| 42 | PKN2 | 1.28091871 |
| 43 | JAK3 | 1.27011289 |
| 44 | PRKCI | 1.24224350 |
| 45 | MATK | 1.20515204 |
| 46 | CSF1R | 1.19155769 |
| 47 | PTK2 | 1.17683552 |
| 48 | NUAK1 | 1.15208239 |
| 49 | SYK | 1.14719191 |
| 50 | PRKD2 | 1.12327978 |
| 51 | DMPK | 1.11748550 |
| 52 | STK10 | 1.10129188 |
| 53 | IRAK4 | 1.10090667 |
| 54 | MAPK7 | 1.06787974 |
| 55 | MAP2K1 | 1.06029442 |
| 56 | HCK | 1.05051772 |
| 57 | JAK1 | 1.04811713 |
| 58 | PDPK1 | 1.02565721 |
| 59 | MAP3K8 | 1.00316583 |
| 60 | TTK | 1.00010596 |
| 61 | SIK2 | 0.98140321 |
| 62 | HIPK2 | 0.97373557 |
| 63 | SIK3 | 0.96714573 |
| 64 | ACVR1B | 0.94825125 |
| 65 | TESK2 | 0.91282425 |
| 66 | RIPK4 | 0.91042027 |
| 67 | EPHB1 | 0.89314990 |
| 68 | FGFR3 | 0.89274119 |
| 69 | TEC | 0.88040786 |
| 70 | RPS6KL1 | 0.87567399 |
| 71 | RPS6KC1 | 0.87567399 |
| 72 | MAP3K7 | 0.86057184 |
| 73 | MAPK12 | 0.84577017 |
| 74 | LCK | 0.84356619 |
| 75 | RPS6KA2 | 0.84355739 |
| 76 | LYN | 0.83614277 |
| 77 | MAP3K1 | 0.81493364 |
| 78 | TGFBR2 | 0.80653962 |
| 79 | OXSR1 | 0.78326511 |
| 80 | JAK2 | 0.78293567 |
| 81 | FER | 0.78161467 |
| 82 | PAK4 | 0.77775393 |
| 83 | ERBB2 | 0.76440436 |
| 84 | RPS6KA6 | 0.75416809 |
| 85 | CDK12 | 0.75191497 |
| 86 | CAMK2D | 0.73522070 |
| 87 | SMG1 | 0.72105035 |
| 88 | IKBKB | 0.71179155 |
| 89 | IKBKE | 0.69476090 |
| 90 | RET | 0.68013117 |
| 91 | PRKAA2 | 0.66524043 |
| 92 | EPHA3 | 0.65919655 |
| 93 | KDR | 0.65822460 |
| 94 | TXK | 0.65119920 |
| 95 | ICK | 0.64950439 |
| 96 | PDK1 | 0.64747081 |
| 97 | CAMKK1 | 0.62281278 |
| 98 | MAPK11 | 0.60514451 |
| 99 | MAP2K6 | 0.58902065 |
| 100 | DAPK2 | 0.57889290 |
| 101 | ARAF | 0.56863105 |
| 102 | TTN | 0.55124453 |
| 103 | MAP3K11 | 0.54871202 |
| 104 | WNK3 | 0.54568881 |
| 105 | CHUK | 0.53200154 |
| 106 | FYN | 0.53109817 |
| 107 | MARK3 | 0.51701086 |
| 108 | LIMK1 | 0.51648318 |
| 109 | PIM2 | 0.51490979 |
| 110 | IRAK1 | 0.51467102 |
| 111 | CSK | 0.50767580 |
| 112 | MAP3K9 | 0.47693663 |
| 113 | MAP3K3 | 0.47459399 |
| 114 | PDK2 | 0.47355916 |
| 115 | PDGFRB | 0.46601564 |
| 116 | MTOR | 0.45997094 |
| 117 | INSRR | 0.45965926 |
| 118 | PRKAA1 | 0.43735612 |
| 119 | BMX | 0.43218617 |
| 120 | CDC42BPA | 0.42903130 |
| 121 | PRKD1 | 0.42810258 |
| 122 | MAPK4 | 0.42697707 |
| 123 | NLK | 0.41639989 |
| 124 | MAPK3 | 0.41429426 |
| 125 | CDK6 | 0.41269573 |
| 126 | STK39 | 0.39937071 |
| 127 | PRKCA | 0.39229063 |
| 128 | LATS1 | 0.38662364 |
| 129 | BRAF | 0.37925771 |
| 130 | LRRK2 | 0.37017923 |
| 131 | CAMK2G | 0.34992634 |
| 132 | AURKB | 0.34009812 |
| 133 | DYRK1B | 0.32799631 |
| 134 | SRC | 0.32520856 |
| 135 | PAK1 | 0.30882499 |
| 136 | PAK3 | 0.30578900 |
| 137 | SCYL2 | 0.29693384 |
| 138 | CAMK2B | 0.29674065 |
| 139 | PDGFRA | 0.29273716 |
| 140 | MAP3K12 | 0.29230918 |
| 141 | PAK2 | 0.27716441 |
| 142 | ERBB4 | 0.26841692 |
| 143 | MELK | 0.26061498 |
| 144 | STK11 | 0.26053439 |
| 145 | MAPKAPK2 | 0.25907501 |
| 146 | MAPK15 | 0.24748521 |
| 147 | PRKACG | 0.23442165 |
| 148 | ROCK1 | 0.22034572 |
| 149 | CSNK1A1 | 0.21556253 |
| 150 | GRK1 | 0.20470799 |
| 151 | GSK3A | 0.20381101 |
| 152 | PBK | 0.20291419 |
| 153 | ITK | 0.19671504 |
| 154 | FGFR4 | 0.18137186 |
| 155 | CDK9 | 0.17895336 |
| 156 | AKT2 | 0.16392129 |
| 157 | PRKCD | 0.16128790 |
| 158 | FGR | 0.14131881 |
| 159 | MAP3K14 | 0.13494838 |
| 160 | EEF2K | 0.12941313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.63512336 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.62329424 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.50801471 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 4.24341253 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.42221380 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.95798083 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.59214619 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.50293578 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.49360260 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20870416 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18449419 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.15931659 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.14167295 |
| 14 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.13739482 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09399119 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.07151826 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.01510327 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01475174 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.96806243 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95023285 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.77744342 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77376805 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.72457378 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.70234008 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69518361 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64109537 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57080232 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56563090 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54803100 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48737755 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44787433 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43149254 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.39685206 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38927990 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37697537 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35635527 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.28943887 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28272604 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26481894 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24832988 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.23982572 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20306936 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18569859 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18253756 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13833562 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08783733 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08235905 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07678990 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.05610402 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05194005 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05166299 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05056567 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.03384053 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02479831 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01145157 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00730600 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00584523 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99364943 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98367311 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97418481 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95730933 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94938089 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.94367600 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.92791992 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92153262 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91393770 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89087224 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88662080 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87389552 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87305650 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87148401 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86367100 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83976762 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83692789 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82683007 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82481287 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82077910 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81315219 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80283374 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.79559697 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78916479 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77714758 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75849768 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74954142 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73489163 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72039233 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71522179 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71319213 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70859164 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70083739 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69785868 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69007849 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68192691 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67945457 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.67469170 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66813653 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66571353 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.66154616 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65889595 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.65786777 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64897190 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.64800570 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63723407 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62870115 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62740493 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62665487 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61428998 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61272765 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60669194 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60105498 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59461847 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59214338 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.57945618 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56710925 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55998890 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54955942 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54527515 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53944641 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52211627 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52091186 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51782500 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48216076 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48174091 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.47513928 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46523780 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46413729 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45978583 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.45853782 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45191080 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.45047695 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41088170 |
| 132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40836052 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.40714193 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.40177155 |
| 135 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38209104 |
| 136 | Peroxisome_Homo sapiens_hsa04146 | 0.37923197 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37906468 |
| 138 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36159787 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35863420 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35818850 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35242205 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34176410 |
| 143 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.30939178 |
| 144 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30085168 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27600609 |
| 146 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26593065 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26439139 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.24924072 |
| 149 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23386094 |
| 150 | Alzheimers disease_Homo sapiens_hsa05010 | 0.18623510 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18466695 |
| 152 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17874494 |
| 153 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16654014 |
| 154 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16253704 |
| 155 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16060372 |
| 156 | Lysine degradation_Homo sapiens_hsa00310 | 0.14896968 |
| 157 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14675452 |
| 158 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14421348 |
| 159 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12779403 |
| 160 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.08032982 |
| 161 | Pertussis_Homo sapiens_hsa05133 | 0.06967100 |
| 162 | Insulin resistance_Homo sapiens_hsa04931 | 0.06731393 |

